Aprinoia

Aprinoia is a biotech company in Taiwan. It has raised $51.1M across 2 rounds, most recently a $40.0M Series C in 2021 (est.).

Home | APRINOIA Therapeutics

Business Model
B2B
Total Funding
$51.1M
Last Round
$40.0M Series CJan 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

APRINOIA is a clinical-stage biotech company committed to protecting patients' brain health and changing outcomes for a broad range of neurodegenerative diseases through best-in-class diagnostic tools and novel therapies. The company's name merges the Latin word for sunlight, "apricum," with the Greek suffix for mind, "noia," reflecting its mission to shed light on better ways to diagnose and treat these disorders.

Summary

It has raised $51.1M in total across 2 rounds, most recently a $40.0M Series C round in 2021 (est.). Investors include Daiwa Corporate Investment, KTB Network and DCI Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries C2021 (est.)
$40.0M

Sign up to see all 2 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aprinoia on Indexed.vc
<a href="https://indexed.vc/companies/aprinoia"><img src="https://indexed.vc/api/badge/company/aprinoia" alt="Aprinoia on Indexed.vc" width="260" height="76" /></a>